Pharmaceutical companies are facing a potential hit as President Trump considers imposing tariffs on pharmaceutical imports, causing stock prices to fall. Companies like Johnson & Johnson, Eli Lilly, and Merck are already investing billions in expanding their manufacturing in the US in anticipation of the tariffs. European-based companies like AstraZeneca and GSK are also monitoring the situation closely, as trade groups warn of a potential shift to the US market if the EU does not strengthen its regulations.
Full Article
Loss of FEMA program spells disaster for hundreds of communities and their projects
FEMA's Elimination of the BRIC Program FEMA's recent decision to eliminate the Building Resilient Infrastructure and Communities (BRIC) program has resulted in the loss of over $3.6 billion in federal funding for communities like Mount Pleasant, North Carolina, which were set to use the funds for vital infrastructure improvements aimed at disaster preparedness. Local officials, including Lafourche Parish President Archie Chaisson, have expressed dismay over the decision, emphasizing the importance of such funding for enhancing...
Read more